MANNITOL INJECTION, USP
Google image searchProduct monograph
Active ingredient
mannitol, 25 %
DIN: 02243176
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Ethical
Company: FRESENIUS KABI CANADA LTD
Date: 19-OCT-2022
ATC:
- B05 — BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS (ATC, ATC/DDD, )
- B05B — I.V. SOLUTIONS (ATC, ATC/DDD)
- B05BC — Solutions producing osmotic diuresis (ATC, ATC/DDD)
- B05BC01 — MANNITOL (ATC/DDD)
Reference brand drug: Osmitrol
Pharmaceutical standard: USP
